Expand   Collapse                             Search

Show details for 20142014
Hide details for 20152015
Show details for 0101
Show details for 0202
Show details for 0303
Show details for 0404
Show details for 0505
Show details for 0606
Show details for 0707
Show details for 0808
Hide details for 0909
09/29/201508:00 AMDisplaying Futures: Merck KGaA, Darmstadt, Germany, Shapes New Focus at Adaptive Architectures and Smart Materials ConferencePM_HarvConfEMD.pdf LCW_300dpi.jpg
09/28/201507:45 AMEMD Millipore Publishes White Paper Highlighting Importance of Emerging Biotech Companies for Discovery of New Drugs During Recent Emerging Biotech Executive SummitUdit_Batra.jpg EMD_Millipore_Emerging_Bio.pdf
09/28/201508:00 AMMerck KGaA, Darmstadt, Germany, Progresses Toward Completion of Sigma-Aldrich AcquisitionBerndReckmann.jpg Progress_SiAl_US.pdf
09/25/201501:00 PMMerck KGaA, Darmstadt, Germany, and Pfizer Announce FDA Orphan Drug Designation for Investigational Immunotherapy Avelumab in Merkel Cell CarcinomaHome-Carousel-Main-1.jpg Alliance_MCC_ODD_US.pdf
09/24/201511:00 PMMerck KGaA, Darmstadt, Germany, and Pfizer Collaborate with Dako, an Agilent Technologies Company, on Development of Companion Diagnostic for Investigational anti-PD-L1 Antibody, AvelumabAbout.jpg Alliance_Dako_US.pdf
09/21/201510:00 AMNew Depth with Xirallic® NXT Tigris Blue from Merck KGaA, Darmstadt, Germany150921TigrBlueEMD.pdf XirallicNXT_TigrisBlue.jpg
09/18/201509:00 AMMerck KGaA, Darmstadt, Germany, and Tridonic Enter Into License Agreement for White LEDsMerckTridonic_EMD_20150918.pdf
09/15/201503:00 PMMerck KGaA, Darmstadt, Germany, Streamlines Healthcare Management as Business Enters New Strategic PhasePress_release_HEC_US.pdf iONC-Perspectives-Blog2A.jpg
09/14/201503:00 PMEMD Millipore Introduces Enhancements to its EMPROVE® Program of Pharmaceutical Raw Materials to Facilitate Risk AssessmentEMD_MIL_EMPROVE_Release_91015.pdf Andrew%20Bulpin%20Headshot.jpg
09/11/201510:00 AMMerck KGaA, Darmstadt, Germany, and Pfizer to Present Updates for Avelumab at the European Cancer Congress 2015iONC-Perspectives-Blog2A.jpg Alliance_ECC_Curtain_Raiser_US.pdf
09/11/201508:00 AMMerck KGaA, Darmstadt, Germany, Intends to Submit Cladribine Tablets to Treat Multiple Sclerosis for Registration in Europe neuron.jpg CladribineUS.pdf
Show details for 1010
Show details for 1111
Show details for 1212
Show details for 20162016
Show details for 20172017
Show details for 20182018

   Expand   Collapse                             Search